Group One Trading’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-357
| Closed | -$8.77K | – | 8958 |
|
|
2025
Q2 | $8.53K | Sell |
357
-3,760
| -91% | -$94.8K | ﹤0.01% | 6813 |
|
|
2025
Q1 | $102K | Sell |
4,117
-5,212
| -56% | -$125K | ﹤0.01% | 4586 |
|
|
2024
Q4 | $176K | Sell |
9,329
-6,918
| -43% | -$121K | ﹤0.01% | 4047 |
|
|
2024
Q3 | $245K | Buy |
16,247
+10,615
| +188% | +$181K | ﹤0.01% | 3436 |
|
|
2024
Q2 | $161K | Sell |
5,632
-161
| -3% | -$4.58K | ﹤0.01% | 3574 |
|
|
2024
Q1 | $169K | Buy |
5,793
+3,508
| +154% | +$108K | ﹤0.01% | 3704 |
|
|
2023
Q4 | $77.1K | Sell |
2,285
-2,638
| -54% | -$77.2K | ﹤0.01% | 4691 |
|
|
2023
Q3 | $151K | Buy |
+4,923
| New | +$177K | ﹤0.01% | 4058 |
|
|
2022
Q1 | – | Sell |
-76
| Closed | -$5.07K | – | 8511 |
|
|
2021
Q4 | $5K | Buy |
+76
| New | +$4.19K | ﹤0.01% | 7644 |
|
|
2021
Q3 | – | Sell |
-2,315
| Closed | -$133K | – | 8630 |
|
|
2021
Q2 | $140K | Hold |
2,315
| – | – | ﹤0.01% | 5608 |
|
|
2021
Q1 | $162K | Sell |
2,315
-394
| -15% | -$28.1K | ﹤0.01% | 5228 |
|
|
2020
Q4 | $162K | Buy |
2,709
+700
| +35% | +$41K | ﹤0.01% | 4219 |
|
|
2020
Q3 | $121K | Buy |
2,009
+1,751
| +679% | +$102K | ﹤0.01% | 4063 |
|
|
2020
Q2 | $14K | Buy |
+258
| New | +$10.8K | ﹤0.01% | 4999 |
|
|
2019
Q2 | – | Sell |
-5,411
| Closed | -$230K | – | 5286 |
|
|
2019
Q1 | $206K | Sell |
5,411
-3,111
| -37% | -$121K | ﹤0.01% | 2680 |
|
|
2018
Q4 | $367K | Buy |
+8,522
| New | +$398K | ﹤0.01% | 2209 |
|
|
2018
Q2 | – | Sell |
-21,508
| Closed | -$743K | – | 5366 |
|
|
2018
Q1 | $670K | Buy |
+21,508
| New | +$766K | 0.01% | 1812 |
|
|
2017
Q4 | – | Sell |
-10,423
| Closed | -$413K | – | 5124 |
|
|
2017
Q3 | $391K | Buy |
+10,423
| New | +$419K | ﹤0.01% | 2273 |
|
|
2017
Q1 | – | Sell |
-3,029
| Closed | -$131K | – | 4909 |
|
|
2016
Q4 | $98K | Sell |
3,029
-11,457
| -79% | -$382K | ﹤0.01% | 2856 |
|
|
2016
Q3 | $496K | Buy |
+14,486
| New | +$568K | 0.01% | 1824 |
|
|
2016
Q2 | – | Sell |
-4,597
| Closed | -$226K | – | 4862 |
|
|
2016
Q1 | $244K | Sell |
4,597
-11,555
| -72% | -$676K | ﹤0.01% | 2195 |
|
|
2015
Q4 | $1.24M | Buy |
16,152
+2,622
| +19% | +$148K | 0.01% | 1163 |
|
|
2015
Q3 | $556K | Buy |
13,530
+1,990
| +17% | +$122K | 0.01% | 1693 |
|
|
2015
Q2 | $816K | Sell |
11,540
-4,149
| -26% | -$327K | 0.01% | 1382 |
|
|
2015
Q1 | $1.39M | Buy |
+15,689
| New | +$1.59M | 0.02% | 842 |
|
|
2014
Q3 | – | Sell |
-7,781
| Closed | -$757K | – | 5373 |
|
|
2014
Q2 | $715K | Sell |
7,781
-6,166
| -44% | -$470K | 0.01% | 1368 |
|
|
2014
Q1 | $976K | Buy |
+13,947
| New | +$949K | 0.02% | 1109 |
|
|
2013
Q3 | – | Sell |
-6,710
| Closed | -$245K | – | 5494 |
|
|
2013
Q2 | $195K | Buy |
+6,710
| New | +$194K | ﹤0.01% | 2196 |
|
Other funds holding PCRX
DPCM
VPM
VCM
Group One Trading's PCRX Position: Q3 2025 in Review
Group One Trading sold out of Pacira BioSciences (PCRX) in Q3 2025, closing a stake of 357 shares — an estimated $8.77K sold.
Group One Trading first reported a position in PCRX in Q2 2013 and held it in 28 quarters. The position peaked at $1.39M in Q1 2015. 239 funds tracked by Wall St. Rank hold PCRX as of Q3 2025.
- Group One Trading reported no remaining Pacira BioSciences position as of Q3 2025 after selling out during the quarter.
- Group One Trading sold 357 Pacira BioSciences shares in Q3 2025, an estimated $8.77K.
- Group One Trading first reported a position in Pacira BioSciences in Q2 2013 and held it in 28 quarters.
- Group One Trading's Pacira BioSciences position peaked at $1.39M in Q1 2015.
- 239 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2025.
Based on Group One Trading's 13F filing for Q3 2025, filed 12 Nov 2025.